UBS (Lux) Equity Fund - Sustainable Health Transformation (USD) F-acc

Reference Data

ISIN LU2418149048
Valor Number 115153863
Bloomberg Global ID UBHTUFU LX
Fund Name UBS (Lux) Equity Fund - Sustainable Health Transformation (USD) F-acc
Fund Provider UBS Asset Management Switzerland AG, Zurich 8098 Zürich, Schweiz
E-Mail: ubs-am-wholesale-switzerland@ubs.com
Web: www.ubs.com/fonds
Fund Provider UBS Asset Management Switzerland AG, Zurich
Representative in Switzerland UBS Fund Management (Switzerland) AG
Basel
Phone: +41 61 288 49 10
Distributor(s) UBS Global Asset Management
Basel
Phone: +41 61 288 20 20
Asset Class Equities
EFC Category Equity Health Care
Distribution Policy Accumulation
Home Country Luxembourg
Issuing Condition The fund management company and/or distributor charges an issuing commission (different commissions can be charged for the same fund depending on the sales channel)
Redemption Condition The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV)
Investment Strategy *** The Fund’s investment objective consists in generating strong capital appreciation with a reasonable level of income, while giving due consideration to capital security and the liquidity of the Fund’s assets. This sub-fund is a Sustainability Focus Fund. This sub-fund promotes environmental and/or social characteristics and complies with Article 8 of Regulation (EU) 2019/2088 on sustainability-related disclosures in the financial services sector (“SFDR”). This actively managed sub-fund invests at least two thirds of its assets worldwide in shares or other equity interests of companies in developed or emerging markets, which mainly promote United Nations Sustainable Development Goal 3 (Good Health and Well-Being). The focus is on companies that capitalise on healthcare transformation.
Peculiarities

Fund Prices

Current Price * 109.70 USD 17.04.2025
Previous Price * 110.65 USD 16.04.2025
52 Week High * 126.23 USD 30.08.2024
52 Week Low * 104.76 USD 07.04.2025
NAV * 109.70 USD 17.04.2025
Issue Price * 109.70 USD 17.04.2025
Redemption Price * 109.70 USD 17.04.2025
Closing Price *
Indicative Minimum Price
Fund Assets *** 232,267,192
Unit/Share Assets *** 35,318,656
Trading Information SIX

Performance

YTD Performance -1.77% 31.12.2024
17.04.2025
YTD Performance (in CHF) -11.34% 31.12.2024
17.04.2025
1 month -5.43% 17.03.2025
17.04.2025
3 months -3.77% 17.01.2025
17.04.2025
6 months -9.66% 17.10.2024
17.04.2025
1 year +3.51% 17.04.2024
17.04.2025
2 years +7.33% 17.04.2023
17.04.2025
3 years +2.82% 19.04.2022
17.04.2025
5 years +9.70% 04.03.2022
17.04.2025

Tax Data

Equity Participation Rate in %
Share of Total Fund Assets in %
Real Estate Rate in %
ADDI
ADDI Date

Top 10 Holdings ***

UnitedHealth Group Inc 10.23%
Eli Lilly and Co 9.65%
AstraZeneca PLC 6.77%
Bristol-Myers Squibb Co 5.27%
Koninklijke Philips NV 5.18%
Intuitive Surgical Inc 5.02%
Alcon Inc 4.84%
Sandoz Group AG Registered Shares 4.25%
Novartis AG Registered Shares 4.06%
Chugai Pharmaceutical Co Ltd 4.03%
Last data update 31.03.2025

Cost / Risk

TER 0.70%
TER date 30.11.2024
Performance Fee *** 0.00%
PTR
Max. Management Fee *** 0.52%
Ongoing Charges *** 0.68%
SRRI ***
SRRI date *** 31.03.2025

Breakdowns

Countries ***

Stock Sectors ***

Bond Sectors ***


* NAV / Issue Price exclusive commissions, for listed funds NAV or closing price
** Calculation of interim profit followed § 9 Satz 2 InvStG
*** Data source: Morningstar (Data is based on the rescaled long position of the holdings)